CN Patent

CN115315253A — 用于治疗眼部病症的组合物和方法

Assigned to Chiola Pharmaceutical Co ltd · Expires 2022-11-08 · 4y expired

What this patent protects

本公开内容涉及用于用掺入到水凝胶中的低水溶性或差水溶性的治疗剂治疗眼部病症或疾病的组合物和方法。特别地，本公开内容涉及非模糊的含治疗剂的水凝胶组合物，其在眼睛上具有延长的接触时间并且不干扰伤口愈合。

USPTO Abstract

本公开内容涉及用于用掺入到水凝胶中的低水溶性或差水溶性的治疗剂治疗眼部病症或疾病的组合物和方法。特别地，本公开内容涉及非模糊的含治疗剂的水凝胶组合物，其在眼睛上具有延长的接触时间并且不干扰伤口愈合。

Drugs covered by this patent

Patent Metadata

Patent number
CN115315253A
Jurisdiction
CN
Classification
—
Expires
2022-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Chiola Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.